Suggest Treatment For Chronic Hepatitis C
ssdi pending.i will give you 50..00 if i collect on your answer
Chronic hepatitis C-treatment
Detailed Answer:
Hi,
Thank you for your query. I can understand your concerns.
Chronic hepatitis C is curable.
I like to know what is your HCV genotype .Treatment success depends on HCV genotype.
Patient variables tend to correlate with sustained virologic responsiveness
Treatment with the combination of PEG IFN and ribavirin
increases responsiveness (frequency of sustained virologic response/SVR) to as high as 55% overall,to >40% in genotypes 1 and 4, and to >80% in genotypes 2 and 3.
Duaration of courses also varies .For patients treated with combination IFNribavirin,therapy for those with genotype 1 should last a full 48
weeks, whereas in those with genotypes 2 and 3, a 24-week course
of therapy suffices.
Tailoring of treatment duration is often required based on rapidity of response or associated cofactors(gender,obesity, insulin resistance, and type 2 diabetes mellitus)
In your case you needed 2nd course for SVR.
Absence of HCV RNA in serum and liver have been documented a decade after successful therapy, and “relapses” 2 years after sustained responses are almost
unheard of.
For all practical purposes,you willbe cleared of the virus eventually.
Some of the side effects of therapy which you are having will gradually wear off and you will be back to your work and employment. Remain assured.
Regards
Dr. T.K. Biswas M.D. XXXXXXX
Chronic hepatitis C-treatment and side effects of Pegasys
Detailed Answer:
Hi,
Thank you for your query. I can understand your concerns.
Both interferon and Pegasys (peginterferon alfa-2a) can cause
CNS side effects like : Depression, irritability, anxiety; dizziness; concentration impairment; memory impairment etc.
Dose reduction is required for moderate to severe adverse reactions that too for
hematologic toxicity,renal function impairment or hepatic function impairment.
As I have already said therapy for those with genotype 1 should last a full 48
weeks.
Discontinuation for any reason are less frequent in patients treated
with Pegasys (peginterferon alfa-2a) than standard-dose PEG IFN-α2b.
In view of chronic HCV infection and increased liver-related mortality,the benefit of treatment far outweighs short-term CNS side effects.
Have patience.
Regards
Dr. T.K. Biswas M.D. XXXXXXX